64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery. The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specific focus on those used for cell and gene therapies.

ALICE Technologies is the developer of an AI-powered construction simulation platform. It leverages artificial intelligence to analyze a project's complex building requirements, generate efficient building schedules, and tune those schedules as needed during construction. The company's platform enables contractors and owners to plan, bid, and build more effectively, reducing construction times and labor costs by $30 million for a typical $500 million construction project. ALICE Technologies works with construction leaders in the infrastructure and commercial construction segments, such as Parsons, HDCC, and Kajima Corporation.

ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.

Beeflow applies scientific knowledge and technologies to bee pollination. Providing professional pollination services to farmers increases crop yields while reducing bee population decline. Since first started 4 years ago in Argentina, the company has increased between 20-90% crop yields in Blueberries, Almonds, Raspberries, and Kiwifruit.

Cambrian Biopharma is a private, clinical-stage biopharmaceutical company focused on developing therapies to prevent and cure age-related diseases. Cambrian is based in New York City with operations across the US and Europe. Cambrian Biopharma is a biotech venture capital holding company that helps scientists transmit their discoveries from the lab into the clinic. Cambrian is uniquely focused on a specific field of biomedical research: the biology of aging, also known as geroscience. Cambrian is built on an emerging business model that we call a ‘Distributed R&D Company’ or ‘DisCo’ that blends the best aspects of the venture capital firm with the capital efficient, agile domain expertise of a mid-sized biotech company. We partner with academic geroscientists to build companies, manage preclinical drug discovery, and finance clinical trials. We have launched 10 companies with leading geroscientists globally. Founded in 2019, Cambrian is a team of over 20 scientist-entrepreneurs, venture capitalists, pharma veterans, and drug hunters located in New York, San Diego, Oxford, Sydney, Frankfurt and London.

Commonwealth Fusion is a research company that develops energy through an inexhaustible power plant. It uses rare-earth barium copper oxide superconductor technology to develop energy. They combine proven physics backed by decades of government-funded fusion research with a revolutionary superconducting magnet technology to accelerate the path to commercial fusion energy Commonwealth Fusion Systems (CFS) is on track to bring fusion energy technology to the market. CFS was spun out of MIT and is collaborating with MIT’s Plasma Science and Fusion Center to leverage decades of research combined with the innovation and speed of the private sector. The business designs and builds fusion machines that deliver limitless and clean fusion energy and integrate proven physics with magnet technology, allowing clients to contribute to the expansion of renewable energy while mitigating the effects of climate change.

Copernic Catalysts develops sustainable chemical catalysts and processes.

Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI.

Earthshot Labs an open-source community, public benefit technology company, and sustainable asset manager. We are developing the first open-source unified land use model for landowners, investors, and policy makers to scale regenerative land management globally.

Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.

Gameto is a new breed of biotechnology firm dedicated to better understanding and treating infertility and menopause. The company aims to leverage the allogeneic human cellular derivatives of their platform to therapeutic applications for assisted fertility and menopause. Gameto was founded in 2020 and is based in New York.

Traditional cameras rely on an imaging lens which typically consists of several lens elements and a light sensitive sensor. Cameras have been built like this since 1816. Glass has been historically used to make high quality optical elements. We are replacing these elements with deep neural networks that give extreme flexibility when designing our cameras. It allows us to squeeze a huge sensor into an ultra thin module that fits perfectly into a mobile device without the need for protruding bumps. Our cameras bring SLR image quality into your pocket.